Another report showed that miR-203 was positively correlated with the sensitivity of glioma cells to chemotherapy and re-expression of miR-203 increased glioma cells to temozolomide by targeting E2F3 [42]. The gene discussed is E2F3; the disease is central nervous system cancer.